Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 2.260
- -0.050-2.16%
Close Mar 28 16:00 ET
- 2.220
- -0.040-1.77%
Post 20:01 ET
344.26MMarket Cap-25.11P/E (TTM)
2.330High2.220Low632.30KVolume2.330Open2.310Pre Close1.42MTurnover0.55%Turnover RatioLossP/E (Static)152.33MShares3.93052wk High-10.23P/B262.22MFloat Cap1.04052wk Low--Dividend TTM116.03MShs Float830.000Historical High--Div YieldTTM4.76%Amplitude0.500Historical Low2.250Avg Price1Lot Size
Heron Therapeutics News
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Analysts' Top Healthcare Picks: Heron Therapeutics (HRTX), DENTSPLY SIRONA (XRAY)
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)
Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham
Heron Therapeutics Analyst Ratings
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Heron Therapeutics (HRTX) Gets a Buy From Northland Securities
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $5
Heron Therapeutics Analyst Ratings
Heron Therapeutics Analyst Ratings
Heron Therapeutics Analyst Ratings
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call